You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Automated Parkinson's Disease Dopamine Transporter Scan Analysis Fast Track

    SBC: MOLECULAR NEUROIMAGING, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): We hypothesize that for a class of dopamine transporter SPECT agents, an automated software processing package can be developed, which will objectively yield striatal quantitative uptake values for evaluating Parkinson's disease (PD) diagnosis and progression. This fully automated and Objective Striatal Analysis (OSA) package will be able to evaluate subjects r ...

    STTR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  2. Cerebral Perfusion Imaging with 3D Arterial Spin Labeling GRASE MRI

    SBC: ADVANCED MRI TECHNOLOGIES LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Arterial spin labeling (ASL) has proven its ability to non-invasively measure cerebral blood flow (CBF). However, widespread use of this promising technique has been prevented by its long acquisition time due to the inherently image low signal-to-noise ratio (SNR). Recently, it has been shown that the use of 3D instead of 2D 'single-shot' sub-second imaging se ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  3. Novel Therapy for Multiple Sclerosis (SBIR-Phase II)

    SBC: COGNOSCI INC            Topic: N/A

    DESCRIPTION (provided by applicant): Multiple sclerosis (MS) is a devastating inflammatory and neurodegenerative disorder of the central nervous system (CNS). Currently, there are no effective treatments for Primary Progressive forms of MS (PP-MS) and more than half of Relapsing Remitting forms of MS (RR-MS) fail to respond to existing therapies generating a critically unmet medical need. The ulti ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  4. Phase II Development of Online SSP and ESSP

    SBC: FLYING BRIDGE TECHNOLOGIES            Topic: N/A

    DESCRIPTION (provided by applicant): In spite of many seemingly positive trends in U.S. educational settings, many children are still not succeeding in school (Powers, 2005), and school failure is strongly associated with race/ethnicity and SES. School success is a vital protective factor against health risk behaviors in adolescence. Addressing threats to school success in adolescence is imperativ ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  5. Advanced Geospatial Computing

    SBC: REPLICUS SOFTWARE CORP.            Topic: NGA05001

    We propose to deliver a system prototype based on the Adaptive Storage Network (ASN) architecture developed in Phase 1 of the SBIR, in order to demonstrate that a fully-distributed self-organizing approach can meet the needs of scalable storage repositories for the NGA and other governmental and large-enterprise infrastructures. The goal of this project is to make data simply and transparently acc ...

    SBIR Phase II 2006 Department of DefenseNational Geospatial-Intelligence Agency
  6. Submission of Investigational New Drug application to the Federal Drug Administration to support clinical development of topical pirenzepine for CIPN.

    SBC: WinSanTor, Inc.            Topic: NCI

    PROJECT SUMMARY Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating side effect of many first-line chemotherapeutic drugs. Depending on the specific drug and dose regimen, CIPN can afflict between 20-85% of cancer patients receiving these drugs at standard doses and nearly 100% of patients at high drug doses. Many patients with CIPN experience neuropathic pain, and there are no FDA ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  7. Prevention of Children's Tympanostomy Tube Otorrhea

    SBC: O-RAY PHARMA            Topic: NIDCD

    Project Summary Otitis media (infection of the middle ear space) is one of the most common diseases of childhood. Myringotomy with tympanostomy tube (TT) insertion is the most common operation performed on children in the United States. Otorrhea is the most common complication following tube insertion and can occur in up to 17% of ears receiving TT and is often associated with active infection. Cu ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  8. Improving Rehabilitation and Reducing Re-Occurrence of Diabetic Foot Ulcers by Shifting Plantar Pressure with Exo-Tendon & Exo-Skeletal Footwear Systems

    SBC: RESULTS GROUP, LLC            Topic: na

    The assistive exo-skeletal footwear promises to help people regain activities of daily living and to resume and maintain full employment by reducing load on the forefoot, reducing fall risk and augmenting foot propulsion that was lost due to foot amputation, ulceration and claudication. Because the exoskeleton will be inserted into diabetic footwear, it carries the risks associated with use of tha ...

    SBIR Phase II 2018 Department of Health and Human ServicesAdministration for Community Living
  9. High-throughput Biocatalyst Manufacturing for Environmental Biotechnology

    SBC: MICROVI BIOTECH, INC.            Topic: 143

    Project Summary / Abstract A variety of hazardous compounds continue to pose serious and widespread risks to public health and safety in the United States. Organic compounds, in particular, such as chlorinated solvents, hydrocarbons, disinfection byproducts, pesticides, polyaromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and other xenobiotic (not naturally occurring) organic chemic ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  10. Automated image-based biomarker computation tools for diabetic retinopathy

    SBC: EYENUK, INC.            Topic: 100

    AbstractIn this project, we present EyeMark, a system with advanced longitudinal image anal- ysis tools for automated computation of biomarkers for diabetic retinopathy (DR) using retinal fundus images. Specifically, we have developed tools for computation of microan- eurysm (MA) appearance and disappearance rates (jointly known as turnover rates) for use as a biomarker in quantifying DR progressi ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government